$20.84
-0.21-1.00%
At close: -
$21.24
0.41.92%
After Hours: 5:23 PM EDT
Comments
Loading...
NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Earnings Estimates, EPS, And Revenue
NewAmsterdam Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-0.180
Quarterly Revenue
$29.1M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$33.6M
Analyze the earnings history of NewAmsterdam Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
NewAmsterdam Pharma (NAMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
NewAmsterdam Pharma (NAMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NewAmsterdam Pharma (NASDAQ:NAMS) reporting earnings?
NewAmsterdam Pharma (NAMS) is scheduled to report earnings on February 6, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for NewAmsterdam Pharma (NASDAQ:NAMS)?
The Actual EPS was $-0.18, which missed the estimate of $0.00.
What were NewAmsterdam Pharma’s (NASDAQ:NAMS) revenues?
The Actual Revenue was $29.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.